Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infectionResearch Advance Published on 2021-04-082022-10-31 Journal: eLife [Category] COVID-19, MERS, SARS, [키워드] Asymptomatic asymptomatic infection BNT162b2 BNT162b2 mRNA BNT162b2 vaccine booster dose country COVID-19 COVID-19 disease COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine demonstrated evaluate the effect Evidence evidence of First wave HCW HCWs healthcare worker Human Jone of BNT162b2 Pfizer-BioNTech PROTECT reduce reduction in SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission single dose Single-dose symptomatic disease utilised vaccination Vaccine [DOI] 10.7554/eLife.68808 PMC 바로가기 [Article Type] Research Advance
Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on HemodialysisCommunication Published on 2021-04-082022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome addition age anti-SARS-CoV-2 IgG antibody Antibody Response Antibody titer Antibody titers BNT162b2 boost Care Chronic kidney disease CLIA control group Coronavirus-2 correlated COVID-19 dose Effectiveness evaluated HCW healthcare worker healthy Hemodialysis humoral immune response immune immunization Infection Longitudinal data median mRNA-based mRNA-based SARS-CoV-2 vaccine mRNA-based vaccine mRNA-vaccines offer Patient Pfizer-BioNTech protective effect reactivity response SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 vaccine second dose shown significantly lower the antibody response vaccination vulnerable patients was determined [DOI] 10.3390/vaccines9040360 PMC 바로가기 [Article Type] Communication
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested ApproachCOVID-19 질병 및 보고된 알레르기 반응을 예방하기 위한 mRNA 백신: 현재 증거 및 제안된 접근 방식Review Published on 2021-04-012022-09-11 Journal: The journal of allergy and clinical immunology. In [Category] 임상, [키워드] administer allergic allergic reaction Allergic reactions allergy American Americans anaphylaxis authorization Care CDC center clinics conjunction Control coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine current develop disease control drug effective Emergency Emergency use authorization Epidemiology EUA FDA first dose food global pandemic glycol Guidance guidelines Hope identify individual information Moderna mRNA mRNA. offer Pfizer-BioNTech Phase 3 trials polyethylene Polyethylene glycol Polysorbate prevention public health raised reaction reassurance receive recommendation regulatory agencies Regulatory Authorities risk stratification staff Support the vaccine U.S. Food and Drug Administration vaccination Vaccine widespread [DOI] 10.1016/j.jaip.2020.12.047 PMC 바로가기 [Article Type] Review
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsSARS-CoV-2 및 순환 변이체에 대한 mRNA 백신 유도 항체Article Published on 2021-04-012022-09-11 Journal: Nature [Category] MERS, SARS, 변종, 진단, [키워드] anti-SARS-CoV-2 antibody arising binding BNT162b2 Cell circulating variant Clinical efficacy Clinical use Cohort Donor E484K elicited epitope Epitopes expressing IgM and IgG individual injection K417N memory B memory B cell memory B cells Moderna monoclonal antibodies monoclonal antibody mRNA mRNA vaccine mRNA vaccines mRNA-1273 Mutation N501Y N501Y mutation natural infection neutralization neutralize Neutralizing activity Pfizer-BioNTech plasma RBD RBD-specific memory B cells receptor response SARS-CoV-2 SARS-CoV-2 S SARS-CoV-2 variant SARS-CoV-2 variants selected Spike protein stomatitis tested the vaccine the vaccines titre Vaccine Vaccines variants vesicular stomatitis vesicular stomatitis virus Volunteer volunteers was reduced [DOI] 10.1038/s41586-021-03324-6 PMC 바로가기 [Article Type] Article
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021Full Report Published on 2021-03-192022-10-30 Journal: Morbidity and Mortality Weekly Report [Category] COVID-19, [키워드] Connecticut COVID-19 facility Nursing Pfizer-BioNTech resident [DOI] 10.15585/mmwr.mm7011e3 PMC 바로가기 [Article Type] Full Report
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic ConsiderationsReview Published on 2021-03-052022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Activation added adverse event allergic allergic reaction Allergic reactions allergy Anaphylactic reaction anaphylaxis antibody arising AstraZeneca Causality caused Cell complement complications contribute COVID-19 COVID-19 mRNA vaccines COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines current death degranulation Diagnosis disease effective first dose G protein-coupled receptor IgE Immunoglobulin IMPROVE incidence individuals induce Infectious disease Interaction Johnson & Johnson knowledge Kounis syndrome mast cell mechanism medication medications Moderna occur Patient Pfizer-BioNTech Polyethylene glycol potentially life-threatening Pregnancy Prevent public health question reaction reduce mortality response Safe Spread stability Surveillance Symptom therapeutic Treatment tween type I vaccination Vaccine Vaccines while with COVID-19 [DOI] 10.3390/vaccines9030221 PMC 바로가기 [Article Type] Review
Israel’s rapid rollout of vaccinations for COVID-19Integrative Article Published on 2021-01-262022-10-30 Journal: Israel Journal of Health Policy Research [Category] COVID-19, MERS, [키워드] addressed Administered Bahrain Canada Care Characteristics China Combination contributed contributing to country COVID-19 COVID-19 vaccination COVID-19 vaccine criteria distribution dose early phase effective effort extrinsic Factor Factors Government groups Health highest hospitals initial Israelis less National Nurse Pfizer-BioNTech receiving response state Support synergy unique United Kingdom vaccination Vaccine warm while [DOI] 10.1186/s13584-021-00440-6 PMC 바로가기 [Article Type] Integrative Article
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020Full Report Published on 2021-01-152022-10-30 Journal: Morbidity and Mortality Weekly Report [Category] COVID-19, [키워드] COVID-19 Including Pfizer-BioNTech reaction receipt United States [DOI] 10.15585/mmwr.mm7002e1 PMC 바로가기 [Article Type] Full Report
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020Full Report Published on 2020-12-182022-10-30 Journal: Morbidity and Mortality Weekly Report [Category] COVID-19, MERS, [키워드] Committee COVID-19 Interim Pfizer-BioNTech United States [DOI] 10.15585/mmwr.mm6950e2 PMC 바로가기 [Article Type] Full Report